Keyphrases
131I Ablation
11%
131I Scintigraphy
66%
18F-fluorodeoxyglucose (18F-FDG)
11%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
100%
Aggressive Thyroid Cancer
11%
Benign or Malignant
22%
Cellular Origin
11%
Clinical Outcomes
11%
Clinical Suspicion
11%
Cyst
11%
Data Analyzing
11%
Degenerative Disc Disease
11%
Disease Progression
11%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Follicular Cells
11%
Infundibular Cyst
11%
Iodine
11%
Iodine-131 (131I)
100%
Medicaid
11%
Medicare
11%
Near Total Thyroidectomy
11%
Negative Predictive Value
11%
Papillary Carcinoma
11%
Pathological Outcomes
11%
Patient-centered
11%
PET-computed Tomography
11%
Pneumonitis
11%
Positive Predictive Value
11%
Positron Emission Tomography
11%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Recurrence or Metastasis
11%
Retrospective Review
11%
Supraclavicular
11%
Surgical Pathology
11%
Surgical Resection
11%
Thyroglobulin
11%
Thyroid Cancer
100%
Thyroid Cancer Recurrence
33%
True Negative
11%
True Positive
11%
Whole-body
66%
Medicine and Dentistry
Cancer Recurrence
33%
Computed Tomography Studies
11%
Computer Assisted Tomography
11%
Decision Making
11%
Disease Exacerbation
11%
Diseases
11%
False Negative Result
11%
False Positive Result
11%
Fluorodeoxyglucose
88%
Fluorodeoxyglucose F 18
100%
Iodine 131
100%
Medicare
11%
Metastatic Carcinoma
11%
Papillary Carcinoma
11%
Pneumonia
11%
Polyethylene Terephthalate
22%
Positron Emission Tomography
11%
Positron Emission Tomography-Computed Tomography
100%
Recurrent Disease
33%
Scintigraphy
66%
Surgery
11%
Thyroglobulin
11%
Thyroid Cancer
100%
Thyroidectomy
11%